1.Effect of Anti-hypertensive Therapy on the Characteristics of Platelet in Primary Hypertension Patients
Chinese Journal of Hypertension 2006;0(11):-
Objective To study the effect of anti-hypertensive therapy on the characteristics of platelet in essential hypertension(EH) patients. Methods Thirty-two healthy people(CT) and 37 patients with primary hypertension (gradeⅠ) were recruited . Blood pressure and 4 platelet parameters: platelet count (PLT), mean platelet volume (MPV), platelet distribution width (PDW) and platelet hematocrit (PCT) were determined by whole blood automatic analysis apparatus. Results The 4 platelet parameters were increased in hypertension patients compared with healthy people and decreased after anti-hypertensive therapy[PLT:(before 201.8?72.9 vs after 187.1?68.6 )10~ 9 L+{-1}; MPV:(before 10.3?1.9 vs after 10.0?1.9)fL, PDW:(before 15.5?1.1 vs after 15.2?1.0)fL; PCT:(before 0.198%?0.047% vs after 0.187%?0.036%)](P
2.Effect of Pancreatic Kininogenase on Ventriculer Remodeling in Spontaneously Hypertensive Rats
Bushang LIU ; Jiyan LENG ; Jun FU
Chinese Journal of Hypertension 2006;0(11):-
Objective To investigate the effect of pancreatic kininogenase on the expression of matrix metalloproteinases-2 2(MMP-2), transfer growth factor-?_ 1 (TGF-?_ 1 ) and ventriculer remodeling in spontaneously hypertensive rats (SHR). Methods Twenty-four male 15 weeks SHR were randomly divided into three groups: SHR group, pancreatic kininogenase treatment group(PK: 7.2 U/kg?d), captopril treatment group(Cap: 10 mg/kg?d)(n=8 in each), 8 Wister Kyoto were served as control. After four weeks, blood pressure were measured througth carotid artery catherization. Myocardial tissue was stained with VG and pathological changes were studied. MMP-2, TGF-?_ 1 were determined by immunohisto-chemical technique(SP method). Results In pancreatic kininogenase treated SHR, SBP(183?12 vs SHR: 234?23)mm Hg, LVMI(2.89?0.15 vs SHR: 3.06?0.18)mg/g, CVF(0.17?0.03 vs SHR: 0.26?0.05)%, PVCA(0.57?0.26 vs SHR: 0.99?0.47)% and expression of MMP-2, TGF-?_ 1 in SHR were significantly improved (P
3.Plasma hsCRP and Glucose Tolerance in Essential Hypertensive Patients
Chinese Journal of Hypertension 2006;0(11):-
Objective To test the hypothesis that the plasma high sensitivity C-reactive protein (hsCRP) level in essential hypertensive patients were related with various degree of glucose tolerance. Methods One hundred forty six essential hypertensive patients were divided into NGT, IGT and T2DM groups according their OGTT results. Blood pressure and laboratory studies, including hsCRP level were determined. Results (1)Age, gender, body weight, BMI, SBP, DBP, LDL-C and TG index between three group were not significant different among groups; (2)The hsCRP level gradually increased from NGT to T2DM groups (P
4.Correlation of Different Indexes of Arterial Elastic Function
Kaiyu CAI ; Weizhong ZHANG ; Huili QIU
Chinese Journal of Hypertension 2006;0(11):-
Objective To study the correlation of three different indexes of arterial elastic function(PWV, C_ 1 and C_ 2 , AI). Methods 1306 out-patients with hypertension were recruited. Two or three arterial elastic function were measured at the same time. Large and small arterial elastic indexes(C_ 1 and C_ 2 );pulse wave velocity(PWV)and augmentation index (AI) in 428 cases , C_ 1 , C_ 2 and PWV(n=208), C_ 1 , C_ 2 , PWV and AI(n=60). Results C_ 1 was negatively related to PWV and positively related with C_ 2 . No correlation between AI and PWV, AI and C_ 1 and C_ 2 was found. Conclusion PWV, C_ 1 and C_ 2 are consistent for the arterial elastic function measurement. However, little relevance between AI and PWV, AI and C_ 1 and C_ 2 was shown.
5.Blood Glucose Levels and Severity of Coronary Stenosis in Hypertensive Patients
Xiaoling PENG ; Zepeng LIN ; Zhiwei ZHANG ; Guanglin JIN ; Changnong PENG ; Wen WANG
Chinese Journal of Hypertension 2006;0(12):-
Objective To investigate the relationship between blood glucose levels and severity of coronary stenosis in hypertensive patients. Methods Blood pressure, fasting plasma glucose, 2 h plasma glucose, clinical features and coronary angiographic findings were analyzed retrospectively in 540 patients with essential hypertension. Acoording 2 h plasma glucose, patients were stratified into three group: group 1: 2h plasma glucose
6.Combined Ferulic acid and Perinopril Treatment in Essential Hypertension
Xiaojun WANG ; Wenzeng HUANG ; Buyan ZHANG
Chinese Journal of Hypertension 2006;0(12):-
Objective Study the effect of Chuanxiongsu(ferulic acid) combined perindopril or perindopril alone in the treatment of essential hypertension (EH). Methods Sixty patients with EH were divided into two groups randomly and single blindly: group A received Chuanxiongsu combined with perindopril, while group B received perindopril alone(4-8 mg/d) only for four weeks. Plasma endothelin-1 concentration(ET-1) and nitric oxide (NO) concentration were determined with radiommunoassay(RIA). Blood pressure was monitored before and after treatment. Thirty healthy volunteers served as controls. Results SBP in group A was lower than that in group B(138.9?8.1 vs group B 143.1?8.5)mm Hg, P
7.Regional Diastolic Dysfunction of Ventricles in Hypertension Patients
Chinese Journal of Hypertension 2006;0(12):-
LAVP2. Multiple linear regression revealed duration of hypertension, grade of hypertension, age and smoking status were independent determinants for the deterioration of diastolic dysfunction. Conclusion A progressing change in regional diastolic dysfunction from right to left ventricle was found in HT patients. The grade of hypertension and the duration of HT were the major determinants on diastolic dysfunction.
8.Evaluation of Hypertensive Myocardial Fibrosis By Quantitative Myocardial Acoustic Densitometry
Naili DU ; Fang JIA ; Ruizhi DU ; Enkui HAO
Chinese Journal of Hypertension 2006;0(12):-
Objective To evaluate the clinical value of quantitative myocardial acoustic densitometry in myocardial fibrosis in relative to the alteration in serum procollagen type Ⅲ amino-terminal propeptide(PⅢNP) concentration in hypertensive patients. Methods Seventy-five consecutive hypertensive patients were recruited with 75 normal persons served as healthy controls. The indexes of acoustic densitometry were evaluated by echocardiography and the concentrations of the serum PⅢNP peptide by radioimmunoassay. Results Calibrated acoustic intensity in septal(CAI1) and posterior wall(CAI2) in hypertension group(0.88?0.06, 0.73?0.06) were greater than that in healthy control group (0.66?0.19, 0.54?0.06) (P
9.Outcome of Comprehensive Prevention Measures for Hypertension:6 Years Follow Up
Jinrong HUANG ; Chaye HE ; Changyan BIAN
Chinese Journal of Hypertension 2007;0(01):-
Objective To evaluate the long term effect of comprehensive antihypertension treatment. Methods A cohort of 818 staff in an institute was enrolled. Regular health checkup, education and aggressively treatment and prevention of hypertension and its complications were administered and followed up for 6 years. Results In the past six years, the incidence rate of hypertension has been decreased year by year(from 23.7% to 19.0%). The rates of awareness(49.5% to 94.4%), treatment(37.1% to 83.7%), and achievement of target BP goal(19.6% to 82.4%) were increased. Cardiovascular risk factors as well as morbidity and mortality were decreased significantly(P
10.Effect of Simvastatin on Plasma Malondialdehyde LDL (MDA-LDL) and Pregnancy-Associated Plasma Protein (PAPP-A) in Patients of Coronary Heart Disease
Zhihui ZHANG ; Xuping LI ; Kan YANG
Chinese Journal of Hypertension 2007;0(02):-
Objective To examine plasma levels of MDA-LDL and pregnancy-associated plasma protein-A in patients with angiography type lesions Ⅱ(representing plaque rupture with or without thrombosis), and to evaluate the effect of simvastatin on plasma MDA-LDL and PAPP-A. Methods One hundred and ten patients were enrolled and underwent coronary angiography with 85 patients diagnosed as coronary heart disease (CHD) and twenty-five as controls. According to the morphologic types of plaque, the patients with CHD were straitified as type Ⅰ(smooth borders) (n=31) and type Ⅱ(irregular lesions) (n=35) and type Ⅲ (long lesions with irregular surface) group (n=19). The patients in type Ⅱ group received simvastatin (40 mg/d ) for four weeks. The plasma MDA-LDL, PAPP-A, LDL, HDL levels before and after simvastatin treatment were determined. Results Plasma levels of MDA-LDL, PAPP-A in type Ⅱ group was significantly higer than that in the controls group, type Ⅰ group, type Ⅲ group (P